Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors
(Q36883658)
scientific article published on February 2007
scientific article published on February 2007
Language:
Current Data About
Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors
other details
description | scientific article published on February 2007 |
External Links
(P356) |
10.1007/S11864-007-0022-4
|
(P698) |
17634832
|